...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Last Monday, March 9th, 20,000 units of one common share and 1/2 warrant were sold to two parties in Alberta at US$2.72 for US$54,400. The warrants are good for 3 years with an exercise price of US$4.08. (SEDAR)

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply